The intratumoral balance between Tregs versus T effectors (Teffs) cells appears to impact the outcome of the immune system-mediated tumor eradication and numerous attempts are currently underway to reduce the CD25-expressing Tregs cells [2]. This evidence concerns the gene IL2RA and neoplasm.